发明名称 THYMOSIN BETA 4 FOR TREATING MULTIPLE SCLEROSIS
摘要 A method of treatment for treating, preventing, inhibiting or reducing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or for restoring tissue adversely affected by said disease, in a subject, includes administering to a subject in need of such treatment an effective amount of a composition including a peptide agent including amino acid sequence LKKTET or LKKTNT, a conservative variant thereof, or a peptide agent that stimulates production of an LKKTET or LKKTNT peptide, or a conservative variant thereof, in the tissue.
申请公布号 EP1853293(B1) 申请公布日期 2016.12.21
申请号 EP20060718342 申请日期 2006.01.13
申请人 Regenerx Biopharmaceuticals, Inc. 发明人 GOLDSTEIN, Allan L.;FINKELSTEIN, Jack, Jr.
分类号 A61K38/08;A61K38/17;A61K38/18;A61K38/19;A61K38/20;A61K38/21;A61K38/22;G01N33/50 主分类号 A61K38/08
代理机构 代理人
主权项
地址
您可能感兴趣的专利